Deputy Director
Bill & Melinda Gates Foundation
Seattle, WA, United States
Peter Dull is the Deputy Director for Integrated Clinical Vaccine Development within the Global Health Division at the Bill and Melinda Gates Foundation. In this role he provides technical and strategic guidance on clinical development to the foundation’s program strategy teams and external partners. In addition, he leads the foundation’s vaccine development activities for HPV vaccines, including efforts on new product development and reduced dose schedules with a goal to accelerate impact on cervical cancer in developing countries. He joined the foundation in 2014 after 10 years at Novartis Vaccines where he was the Clinical Franchise Head for Meningitis and Sepsis Vaccines, leading the clinical development global licensure of MenACWY-CRM (Menveo) and 4CMenB (Bexsero). During the Covid-19 pandemic, in additional to providing direct support for grantees developing new COVID-19 vaccines, he co-led the COVAX Clinical SWAT team with CEPI partners in providing product-agnostic support to developers to accelerate vaccine licensure and achieve WHO pre-qualification. He also co-chaired the COVAX Clinical SWAT Correlates Working Group with Stanley Plotkin during 2020-2022. Prior to joining Novartis, he was an Epidemic Intelligence Service officer in the Meningitis and Special Pathogens Branch at the US Centers for Disease Control, completed subspecialty training in adult infectious diseases at Emory University and internal medicine residency at Oregen Health & Sciences University.
I do not have any relevant financial / non-financial relationships with any proprietary interests.
Saturday, October 22, 2022
1:45 PM – 3:00 PM US ET
Saturday, October 22, 2022
2:10 PM – 2:35 PM US ET